Trial intelligence / Profile preview

OCEAN3 Lotriga Post-marketing Specified Drug-use Survey

jRCT1080222629Completed

Sponsor
Takeda
Start
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of omega-3-acid ethyl esters in hyperlipidemia, hypertriglyceridemia and cardiac morbidity, sponsored by Takeda. Started Oct 2014; status: completed.

02

Drugs

omega-3-acid ethyl esters
03

Conditions

hyperlipidemiahypertriglyceridemiacardiac morbidity

Beyond the preview

Go deeper on jRCT1080222629.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080222629.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call